Clinical Trials
413
Active:11
Completed:122
Trial Phases
6 Phases
Early Phase 1:2
Phase 1:64
Phase 2:83
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (308 trials with phase data)• Click on a phase to view related trials
Not Applicable
129 (41.9%)Phase 2
83 (26.9%)Phase 1
64 (20.8%)Phase 4
17 (5.5%)Phase 3
13 (4.2%)Early Phase 1
2 (0.6%)HVNI vs NIPPV in Type 2 Respiratory Failure
Not Applicable
Not yet recruiting
- Conditions
- Respiratory FailureHypoxiaHypercapnia
- First Posted Date
- 2025-07-15
- Last Posted Date
- 2025-07-15
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 84
- Registration Number
- NCT07065656
Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS)
Phase 4
Recruiting
- Conditions
- CABG
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 250
- Registration Number
- NCT07031128
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
🇸🇬Singapore General Hospital, Singapore, Singapore
Screening for Early Diagnosis of Nose Cancer
Not Applicable
Recruiting
- Conditions
- Nasopharyngeal Carcinoma
- First Posted Date
- 2025-06-13
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 20000
- Registration Number
- NCT07019870
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
🇸🇬National University Polyclinics, Singapore, Singapore
CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial
Phase 3
Not yet recruiting
- Conditions
- Obstructive Sleep Apnea (OSA)Mild Cognitive Impairment
- First Posted Date
- 2025-05-21
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 260
- Registration Number
- NCT06983769
Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study
Not yet recruiting
- Conditions
- Ischemic StrokePatent Foramen Ovale
- Interventions
- Procedure: PFO closure using approved PFO closure devices, Surgical PFO closureDrug: Medical management
- First Posted Date
- 2025-05-21
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 1000
- Registration Number
- NCT06983795
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
- Prev
- 1
- 2
- 3
- 4
- 5
- 83
- Next
News
No news found